Author: Dr. Terushkin, MD, FACS
This content is for informational purposes only and is not medical advice. Semaglutide and tirzepatide are prescription medications and may not be appropriate for everyone. Always consult a licensed healthcare provider for personalized medical guidance. Results vary.
Semaglutide and tirzepatide have rapidly become two of the most talked-about medications in medical weight loss. With headlines, social media success stories, and dramatic before-and-after photos, many patients arrive with the same question: are these medications a quick fix for weight loss?
From a medical perspective, the answer is clear: no—but they can be highly effective tools when used correctly, safely, and under proper medical supervision.
Semaglutide works by mimicking the GLP-1 hormone, which plays a key role in appetite regulation, insulin secretion, and satiety. Tirzepatide goes one step further by activating both GLP-1 and GIP receptors, offering a dual-hormone approach to metabolic control.
Most patients experience:
These effects help patients naturally consume fewer calories, but they do not bypass biology or lifestyle factors.
Weight gain is rarely caused by willpower alone. Hormonal imbalance, insulin resistance, medications, sleep disruption, stress, and genetics all contribute. Semaglutide and tirzepatide address part of the problem—not the entire picture.
Patients who rely on medication alone or stop treatment abruptly often experience rebound appetite and weight regain. Sustainable weight loss requires a long-term medical strategy, not a temporary intervention.

These medications are most effective for patients who:
They are not designed for cosmetic or short-term weight loss.
At Florida Wellness and Medical Care, treatment includes medical evaluation, lab review, dose titration, and ongoing monitoring. This ensures safety, minimizes side effects, and supports long-term metabolic health.
Safe weight loss typically averages 0.5–2 pounds per week, depending on individual factors.
Medication works best when combined with nutrition awareness, movement, sleep optimization, and regular follow-ups. There are no shortcuts to lasting results.

| Feature | Semaglutide | Tirzepatide |
|---|---|---|
| Medication Class | GLP-1 receptor agonist | GLP-1 + GIP receptor agonist |
| Appetite Control | Strong | Very strong |
| Average Weight Loss | ~10–15% | ~15–22% |
| Blood Sugar Impact | Significant | More pronounced |
| Dosing | Weekly injection | Weekly injection |
| Clinical History | Longer track record | Newer dual-action |
| Best For | Steady, proven results | Higher BMI or insulin resistance |
| Medical Oversight | Required | Required |
Medication choice should always be guided by a licensed healthcare provider.
This content is for informational and educational purposes only and does not constitute medical advice. Semaglutide and tirzepatide are prescription medications and may not be suitable for all individuals. Treatment decisions should be made in consultation with a licensed healthcare provider after a comprehensive medical evaluation. Results vary, and no outcome is guaranteed.
Useful Articles and Blogs
Real people, REAL RESULTS! Medical Weight Loss and Bariatrich Surgery - Check out a few of the many people that we have helped reach their ideal weight goals over the years.
Where Modern Medicine Meets Holistic Healing – Personalized Care That Balances Science, Nature, and Your Unique Health Goals.
Dr. Sergey Terushkin, MD, FACS, is a leading bariatric surgeon now serving patients throughout South Florida in partnership with Florida Wellness & Medical Care in Hollywood, FL. He offers a comprehensive range of weight loss solutions, including Gastric Sleeve, Gastric Bypass, Spatz3 Adjustable Gastric Balloon, Revisional Bariatric Surgery, and post-bariatric procedures such as excess skin removal.